FDA approves new test for HIV 1/2.HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Jan. 3, 1997--The U.S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) has approved the licensure licensure (lī´s  nsh of a test for the AIDS virus AIDS virusn. See HIV. types 1 and 2 (HIV-1,2). The test, manufactured by United Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Inc. (UBI UBI Universidade da Beira Interior (Portugal) UBI Unrelated Business Income UBI Unified Business Identifier UBI United Bank of India UBI UKW-Sprechfunkzeugnis für den Binnenschifffahrtsfunk (R)), Hauppauge, N.Y., is based on synthetic peptides and detects antibodies to the viruses. It is suitable for diagnostic laboratories and blood donor screening. This is the quickest test yet available for blood screening, requiring at least 1/2 to 1-1/2 hours less than the procedures of currently licensed HIV-1,2 screening tests. UBI(R) is a privately held international diagnostic and biopharmaceutical company. UBI(R) is recognized as a leader in the design and manufacture of synthetic peptide products and developed the first synthetic peptide-based blood test for antibodies to HIV-1 approved by the FDA. UBI(R) maintains an FDA licensed manufacturing facility at its corporate headquarters in Hauppauge. CONTACT: United Biomedical Inc., Hauppauge Dr. Barbara Hosein, 516/273-2828 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion